Establishment and characterization of an Epstein-Barr virus-positive cell line from a non-keratinizing differentiated primary nasopharyngeal carcinoma. (2024)
Attributed to:
The identification of genetic vulnerabilities in head and neck cancers for the development of novel therapies.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/2767-9764.crc-23-0341
PubMed Identifier: 38358347
Publication URI: http://europepmc.org/abstract/MED/38358347
Type: Journal Article/Review
Parent Publication: Cancer research communications
ISSN: 2767-9764